In hematology, we have been using Big Data to develop precision diagnostics and precision medicine approaches in blood cancer treatment for a long time already. We have been using genetic diagnostics to stratify patients in order to select the right treatment for the right patient. In addition, Hematologic Malignancies were among the first diseases where targeted therapies were implemented.
One of the driving forces behind precision medicine in hematology is the HARMONY Alliance: a Public-Private Partnership for Big Data in Hematology. Funded by the Innovative Medicines Initiative (IMI) of the EU, HARMONY unites more than 100 European organizations, varying from medical associations and hospitals, to research institutes, patient organizations, pharmaceutical companies, and more.
Big data for big questions
To answer the key outstanding questions about blood cancer, researchers need harmonized and high-quality data on treatment outcomes in thousands of patients. Therefore, the HARMONY Alliance has developed the HARMONY Big Data Platform which has already identified over 70.000 anonymized patient records. Leading research teams are making use of innovative Big Data analytic tools, creating a wealth of information to answer critical questions about these diseases. Results of the HARMONY Projects will accelerate the development of more effective treatments for patients with blood cancers.
by HARMONY Partners: Dr. Guillermo Sanz, Head of the Clinical Hematology Section at Hospital Universitario La Fe from Valencia and HARMONY Co-Chair and Dr. Jesús María Hernández Rivas, specialist of the Hematology Service of the University Hospital of Salamanca and HARMONY Coordinator.
The HARMONY Alliance has launched a #bigdataforbloodcancer communication campaign for you! We are aiming to engage with even more professionals and non-professionals in the field of hematology to explain what Big Data can mean for them in their daily work and for patients. Please contact us if you want to help us improve the lives of patients with blood cancer. Special activities to inform professionals are launched in June during EHA2021*. Special activities for patients and their carers will be launched in September 2021.
Save the date: 30 September 2021. Stay tuned for more information
HARMONY will participate in the 26th Annual Congress of EHA (9-17 June 2021). An excellent opportunity to reach out to all *EHA2021 conference participants about Big Data in Hematology. Contributions by HARMONY Partners will demonstrate the potential of big data to improve blood cancer treatment. Read more about our abstracts and sessions >
Not contributing data, but having a general interest in Big Data in Hematology and in HARMONY? Become part of our network, subscribe here >
Receive the latest news. Click here to subscribe!